Additionally, past efforts to come to scientific consensus on controversial issues have excluded the public, and as a result narrowed the scope of technological risks considered. For example, at the 1975 Asilomar conference on recombinant DNA, scientists addressed the risks of biological contamination during laboratory experiments, but failed to consider the more varied public concerns that would surface with commercial adoption of genetically modified crops.
